Scpharmaceuticals Company Overview
About Scpharmaceuticals
Scpharmaceuticals (NASDAQ:SCPH) is a biopharmaceutical company focused on developing and commercializing products that are designed for subcutaneous delivery for various therapeutic areas. These innovative therapies aim to improve the quality of life for patients with heart failure and infectious diseases, offering a potential alternative to intravenous (IV) treatments that require hospital visits. Their flagship projects include the development of Furoscix, a device for subcutaneous delivery of furosemide, aimed at treating congestion in heart failure patients outside of the hospital setting. Scpharmaceuticals is driven by the objective to provide patients with convenient and effective treatment options, aiming to reduce the burden on healthcare facilities while enhancing accessibility to essential medications.
Snapshot
Operations
Produtos e/ou serviços de Scpharmaceuticals
- Furoscix, a subcutaneous formulation of furosemide designed for at-home treatment of congestive heart failure patients.
- Development of a wearable, user-friendly subcutaneous infusion device aimed at enabling self-administration of Furoscix.
- Research into subcutaneous formulations of other diuretics to expand treatment options for heart failure.
- Initiation of studies to evaluate the efficacy and safety of their subcutaneous drug delivery system for other cardiovascular diseases.
- Collaboration with technology companies to enhance the patient monitoring platform for real-time management of conditions.
- Expansion of their portfolio by exploring novel drug formulations for subcutaneous delivery to address unmet medical needs in chronic diseases.
equipe executiva do Scpharmaceuticals
- Mr. John H. TuckerPresident, CEO, Principal Executive Officer & Director
- Ms. Rachael NokesChief Financial Officer
- Mr. Michael D. HassmanSenior Vice President of Technical Operations
- Ms. Katherine TaudvinVice President of Corporate Affairs & Human Resources
- Dr. John Mohr Pharm.D.Senior Vice President of Clinical Development & Medical Affairs
- Mr. Steve C. ParsonsSenior Vice President of Commercial